Risks, values, and decision making surrounding pregnancy

Obstetrics and Gynecology

Volumn 109, Issue 4, 2007, Pages 979-984

  Lyerly, Anne Drapkin ^b   Mitchell, Lisa M ^b   Armstrong, Elizabeth M ^b   Harris, Lisa H ^b   Kukla, Rebecca ^b   Kuppermann, Miriam ^a   Little, Margaret Olivia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; PERCEPTION; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; RISK MANAGEMENT; SOCIAL ENVIRONMENT; WELLBEING;

DECISION MAKING; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH POLICY; HUMANS; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; RISK ASSESSMENT; VAGINAL BIRTH AFTER CESAREAN;

EID: 34147145337     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000258285.43499.4b     Document Type: Review

References (45)

1. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002;324:827-30.
2. Elmore JG, Gigerenzer G. Benign breast disease: the risks of communicating risk. N Engl J Med 2005;353:297-9.
3. Paling J. Strategies to help patients understand risks. BMJ 2003;327:745-8.
4. Clinical management guidelines for obstetrician-gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. ACOG Practice Bulletin. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;97 suppl:1-12.
5. Wilson RD, Davies G, Gagnon A, Desilets V, Reid GJ, Summers A, et al. Amended Canadian guideline for prenatal diagnosis (2005) change to 2005: techniques for prenatal diagnosis. J Obstet Gynaecol Can 2005;27:1048-54.
6. Aetna. Clinical Policy Bulletin Number 0358: prenatal diagnosis of genetic diseases. Available at: http://www.aetna.com/cpb/data/CPBA0358.html. Retriev ed January 16, 2007.
7. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
8. Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. 2007;109:217-28.
9. Harris RA, Washington AE, Nease RF Jr, Kuppermann M. Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 2004;363:276-82.
10. Pauker SP, Pauker SG. Prenatal diagnosis: why is 35 a magic number? [published erratum appears in N Engl J Med 1994;331:415]. N Engl J Med 1994;330:1151-2.
11. Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol 2000;96:511-6.
12. Lippman A. Embodied knowledge and making sense of prenatal diagnosis. J Genet Counsel 1999;8:255-74.
13. Markens S, Browner CH, Press N. "Because of the risks": how U.S. pregnant women account for refusing prenatal screening. Soc Sci Med 1999;49:359-69.
14. Rapp R. Sociocultural differences in the impact of amniocentesis: an anthropological research report. Fetal Diagn Ther 1993;8 suppl:90-6.
15. Kuppermann M, Goldberg JD, Nease RF, Jr Washington AE. Who should be offered prenatal diagnosis? The 35-year-old question. Am J Public Health 1999;89:160-3.
16. Rapp R. Testing women, testing the fetus: the social impact of amniocentesis in America. New York (NY): Routledge; 1999.
17. Flamm BL. Once a cesarean, always a controversy. Obstet Gynecol 1997;90:312-5.
18. Sachs BP, Kobelin C, Castro MA, Frigoletto F. The risks of lowering the cesarean-delivery rate. N Engl J Med 1999;340:54-7.
19. Vaginal birth after previous cesarean. ACOG Practice Bulletin 54. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;104:203-12.
20. Grady D. Trying to avoid 2nd cesarean: many women find choice isn't theirs. New York Times, November 29, 2004. p. A1.
21. Schneider ME. Insurers set criteria for VBAC coverage. OB GYN News, February 1, 2005. Available at: http:// calbears.findarticles.com/p/ articles/ mi_MOCYD/is_3_40/ai_n11832004. Retrieved January 23, 2007.
22. Smith GC, Pell JP, Cameron AD, Dobbie R. Risk of perinatal death associated with labor after previous cesarean delivery in uncomplicated term pregnancies. JAMA 2002;287:2684-90.
23. Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351:2581-9.
24. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226-32.
25. Merton V. Ethical obstacles to the participation of women in biomedical research. In: Wolf SM, editor. Feminism & bioethics: beyond reproduction. New York (NY): Oxford University Press; 1996. p. 216-51.
26. Steinbock B. Maternal-fetal conflict: pregnant drug addicts. In: Bromham DR, editor. Ethics in reproductive medicine. New York (NY): Springer-Verlag; 1992. p. 49-58.
27. Weiss HB, Songer TJ, Fabio A. Fetal deaths related to maternal injury. JAMA 2001;286:1863-8.
28. Ritz B, Wilhelm M, Zhao Y. Air pollution and infant death in southern California, 1989-2000. Pediatrics 2006;118:493-502.
29. Munoz M, Usatine RP. Abdominal pain in a pregnant woman. J Fam Pract 2005;54:665-8.
30. Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician 1999;59:1813-8, 20.
31. Gray JE. Safety (risk) of diagnostic radiology exposures. In: Janower ML, Linton OW, editors. Radiation risk: a primer. Reston (VA): American College of Radiology; 1996. p. 15-7.
32. Guidelines for diagnostic imaging during pregnancy. ACOG Committee Opinion Number 299. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;104:647-51.
33. Brent RL, Mettler FA. Pregnancy policy. AJR Am J Roentgenol 2004;182:819-22.
34. Barish RJ. The invisible passenger: radiation risks for people who fly. Madison (WI): Advanced Medical Publications; 1996.
35. Donadieu J, Zeghnoun A, Roudier C, Maccia C, Pirard P, Andre C, et al. Cumulative effective doses delivered by radiographs to preterm infants in a neonatal intensive care unit. Pediatrics 2006;117:882-8.
36. Bloom SL, Gilstrap LC. Abdominal pain in pregnancy. In: Pearlman M, Tintinalli JE, editors. Emergency care of the woman. New York (NY): McGraw-Hill; 1998. p. 229-38.
37. Mazze RI, Kallen B. Appendectomy during pregnancy: a Swedish registry study of 778 cases. Obstet Gynecol 1991;77:835-40.
38. Birchard KR, Brown MA, Hyslop WB, Firat Z, Semelka RC. MRI of acute abdominal and pelvic pain in pregnant patients. Am J Roentgenol 2005;184:452-8.
39. Forsted DH, Kalbhen CL. CT of pregnant women for urinary tract calculi, pulmonary thromboembolism, and acute appendicitis. Am J Roentgenol 2002;178:1285.
40. Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health 2005;8:214-20.
41. Koren G, Bologa M, Pastuszak A. Women's perception of teratogenic risk. Can J Public Health 1991;82:S11-4, S33-7.
42. Tan KS, Thomson NC. Asthma in pregnancy. Am J Med 2000;109:727-33.
43. Mastroianni A, Faden R, Federman D, editors. Women and health research:3 ethical and legal issues of including women in clinical studies. Washington, DC: National Academy Press; 1994.
44. Doncel G, Mauck C. Vaginal microbicides: a novel approach to preventing sexual transmission of HIV. Curr HIV/AIDS Rep 2004;1:25-32.
45. Lard-Whiteford SL, Matecka D, O'Rear JJ, Yuen IS, Litterst C, Reichelderfer P. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. J Acquir Immune Defic Syndr 2004;36:541-52.